Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?

A negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristics may remain at unacceptably high risk of axillary disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenneth D. Westover, M. Brandon Westover, Eric P. Winer, Andrea L. Richardson, J. Dirk Iglehart, Rinaa S. Punglia
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.4061/2011/973245
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560355739435008
author Kenneth D. Westover
M. Brandon Westover
Eric P. Winer
Andrea L. Richardson
J. Dirk Iglehart
Rinaa S. Punglia
author_facet Kenneth D. Westover
M. Brandon Westover
Eric P. Winer
Andrea L. Richardson
J. Dirk Iglehart
Rinaa S. Punglia
author_sort Kenneth D. Westover
collection DOAJ
description A negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristics may remain at unacceptably high risk of axillary disease even after a negative SLN biopsy result. A Bayesian nomogram was designed to combine the probability of axillary disease prior to nodal biopsy with customized test characteristics for an SLN biopsy and provides the probability of axillary disease despite a negative SLN biopsy. Users may individualize the sensitivity of an SLN biopsy based on factors known to modify the sensitivity of the procedure. This tool may be useful in identifying patients who should have expanded upfront exploration of the axilla or comprehensive axillary irradiation.
format Article
id doaj-art-e6ab8f8baaa04c2a93ec9be638fc7f9b
institution Kabale University
issn 2090-3189
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-e6ab8f8baaa04c2a93ec9be638fc7f9b2025-02-03T01:27:49ZengWileyInternational Journal of Breast Cancer2090-31892011-01-01201110.4061/2011/973245973245Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?Kenneth D. Westover0M. Brandon Westover1Eric P. Winer2Andrea L. Richardson3J. Dirk Iglehart4Rinaa S. Punglia5Harvard Radiation Oncology Program, Boston, MA 02115, USADepartment of Neurology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USADepartment of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USADepartment of Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USADepartment of Surgery, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USADepartment of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USAA negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristics may remain at unacceptably high risk of axillary disease even after a negative SLN biopsy result. A Bayesian nomogram was designed to combine the probability of axillary disease prior to nodal biopsy with customized test characteristics for an SLN biopsy and provides the probability of axillary disease despite a negative SLN biopsy. Users may individualize the sensitivity of an SLN biopsy based on factors known to modify the sensitivity of the procedure. This tool may be useful in identifying patients who should have expanded upfront exploration of the axilla or comprehensive axillary irradiation.http://dx.doi.org/10.4061/2011/973245
spellingShingle Kenneth D. Westover
M. Brandon Westover
Eric P. Winer
Andrea L. Richardson
J. Dirk Iglehart
Rinaa S. Punglia
Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
International Journal of Breast Cancer
title Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
title_full Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
title_fullStr Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
title_full_unstemmed Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
title_short Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?
title_sort should a sentinel node biopsy be performed in patients with high risk breast cancer
url http://dx.doi.org/10.4061/2011/973245
work_keys_str_mv AT kennethdwestover shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer
AT mbrandonwestover shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer
AT ericpwiner shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer
AT andrealrichardson shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer
AT jdirkiglehart shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer
AT rinaaspunglia shouldasentinelnodebiopsybeperformedinpatientswithhighriskbreastcancer